- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, July 23, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A study published in the July 2021 issue of The American Journal of Managed Care® (AJMC®), titled “Large Self-insured Employers Lack Power to Effectively Negotiate Hospital Prices,” was cited in articles by Healthcare Dive, Fierce Healthcare, and Becker’s Hospital Review. In the study, authors examined the ability of self-insured employers to negotiate hospital prices, with findings showing low market power of employers in most metropolitan areas.
A piece by Healthcare Finance News referenced a study published online ahead of print for the December 2021 issue of AJMC®. The study, “Availability of Prices for Shoppable Services on Hospital Internet Sites,” indicated that many hospitals are in violation of new federal legislation with only 60% of hospitals displaying their cash prices and 5% displaying their minimum negotiated charges on their public websites. The study was also mentioned by the Santa Monica Daily Press.
Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending
August 19th 2025Hospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Read More
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
